CRIS
Price
$1.68
Change
-$0.03 (-1.75%)
Updated
Sep 5 closing price
Capitalization
21M
LSTA
Price
$2.17
Change
+$0.06 (+2.84%)
Updated
Sep 5 closing price
Capitalization
18.66M
61 days until earnings call
Interact to see
Advertisement

CRIS vs LSTA

Header iconCRIS vs LSTA Comparison
Open Charts CRIS vs LSTABanner chart's image
Curis
Price$1.68
Change-$0.03 (-1.75%)
Volume$65.72K
Capitalization21M
Lisata Therapeutics
Price$2.17
Change+$0.06 (+2.84%)
Volume$12.13K
Capitalization18.66M
CRIS vs LSTA Comparison Chart in %
Loading...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRIS vs. LSTA commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIS is a Hold and LSTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CRIS: $1.68 vs. LSTA: $2.17)
Brand notoriety: CRIS and LSTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRIS: 55% vs. LSTA: 28%
Market capitalization -- CRIS: $21M vs. LSTA: $18.66M
CRIS [@Biotechnology] is valued at $21M. LSTA’s [@Biotechnology] market capitalization is $18.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRIS’s FA Score shows that 0 FA rating(s) are green whileLSTA’s FA Score has 1 green FA rating(s).

  • CRIS’s FA Score: 0 green, 5 red.
  • LSTA’s FA Score: 1 green, 4 red.
According to our system of comparison, LSTA is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRIS’s TA Score shows that 5 TA indicator(s) are bullish while LSTA’s TA Score has 3 bullish TA indicator(s).

  • CRIS’s TA Score: 5 bullish, 3 bearish.
  • LSTA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CRIS is a better buy in the short-term than LSTA.

Price Growth

CRIS (@Biotechnology) experienced а +0.60% price change this week, while LSTA (@Biotechnology) price change was -6.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

LSTA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRIS($21M) has a higher market cap than LSTA($18.7M). LSTA YTD gains are higher at: -27.181 vs. CRIS (-45.098). LSTA has higher annual earnings (EBITDA): -20.83M vs. CRIS (-36.02M). LSTA has more cash in the bank: 22M vs. CRIS (10.1M). LSTA has less debt than CRIS: LSTA (47K) vs CRIS (2.31M). CRIS has higher revenues than LSTA: CRIS (11.4M) vs LSTA (1.07M).
CRISLSTACRIS / LSTA
Capitalization21M18.7M112%
EBITDA-36.02M-20.83M173%
Gain YTD-45.098-27.181166%
P/E RatioN/AN/A-
Revenue11.4M1.07M1,065%
Total Cash10.1M22M46%
Total Debt2.31M47K4,913%
FUNDAMENTALS RATINGS
CRIS vs LSTA: Fundamental Ratings
CRIS
LSTA
OUTLOOK RATING
1..100
651
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
18
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6589
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LSTA's Valuation (18) in the null industry is somewhat better than the same rating for CRIS (57) in the Biotechnology industry. This means that LSTA’s stock grew somewhat faster than CRIS’s over the last 12 months.

LSTA's Profit vs Risk Rating (100) in the null industry is in the same range as CRIS (100) in the Biotechnology industry. This means that LSTA’s stock grew similarly to CRIS’s over the last 12 months.

LSTA's SMR Rating (98) in the null industry is in the same range as CRIS (100) in the Biotechnology industry. This means that LSTA’s stock grew similarly to CRIS’s over the last 12 months.

CRIS's Price Growth Rating (65) in the Biotechnology industry is in the same range as LSTA (89) in the null industry. This means that CRIS’s stock grew similarly to LSTA’s over the last 12 months.

CRIS's P/E Growth Rating (100) in the Biotechnology industry is in the same range as LSTA (100) in the null industry. This means that CRIS’s stock grew similarly to LSTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRISLSTA
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 15 days ago
76%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLE0.780.04
+5.11%
Global Engine Group Holding Ltd
PNTG24.290.21
+0.87%
Pennant Group (The)
COLD13.970.04
+0.29%
Americold Realty Trust
HUM307.92-4.08
-1.31%
Humana
VTYX2.52-0.08
-3.08%
Ventyx Biosciences

CRIS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRIS has been loosely correlated with VTGN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CRIS jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRIS
1D Price
Change %
CRIS100%
-1.75%
VTGN - CRIS
38%
Loosely correlated
-1.93%
RAIN - CRIS
38%
Loosely correlated
-3.30%
CGON - CRIS
37%
Loosely correlated
+6.88%
ROIV - CRIS
36%
Loosely correlated
+2.78%
OBIO - CRIS
36%
Loosely correlated
+0.36%
More

LSTA and

Correlation & Price change

A.I.dvisor tells us that LSTA and RAIN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and RAIN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSTA
1D Price
Change %
LSTA100%
+2.84%
RAIN - LSTA
27%
Poorly correlated
-3.30%
LGVN - LSTA
27%
Poorly correlated
+5.84%
ASND - LSTA
26%
Poorly correlated
+3.93%
CRIS - LSTA
26%
Poorly correlated
-1.75%
TPST - LSTA
26%
Poorly correlated
+9.57%
More